reported that osteoblastic bone metastases accounted for more than 90% of osseous metastases of PCa, and PCa patients with bone metastases usually had significantly increased blood PSA levels (≥10 ng/ml in approximately 99% of patients) (2). This evidence concerns the gene KLK3 and posterior cortical atrophy.